chrisvoncsefalvay/vaers-outcomes huggingface dataset:
headaches and difficulty breathing; everything is blurry visually; head starts pounding; sweating; flu-like symptoms; slept from Wednesday to Friday; feels very tired; headaches and difficulty breathing; This spontaneous case was reported by a consumer and describes the occurrence of HYPERHIDROSIS (sweating), INFLUENZA LIKE ILLNESS (flu-like symptoms), HYPERSOMNIA (slept from Wednesday to Friday), FATIGUE (feels very tired) and HEADACHE (headaches and difficulty breathing) in a 39-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included OXYCODONE, MAGNESIUM and Vitamin C                                                      taken daily for an unknown indication.    On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Apr-2021, the patient experienced HYPERHIDROSIS (sweating), INFLUENZA LIKE ILLNESS (flu-like symptoms), HYPERSOMNIA (slept from Wednesday to Friday), FATIGUE (feels very tired), HEADACHE (headaches and difficulty breathing), VISION BLURRED (everything is blurry visually) and HEADACHE (head starts pounding). On 25-Apr-2021, the patient experienced DYSPNOEA (headaches and difficulty breathing). On 23-Apr-2021, HYPERSOMNIA (slept from Wednesday to Friday) had resolved. At the time of the report, HYPERHIDROSIS (sweating), INFLUENZA LIKE ILLNESS (flu-like symptoms), FATIGUE (feels very tired), HEADACHE (headaches and difficulty breathing), DYSPNOEA (headaches and difficulty breathing), VISION BLURRED (everything is blurry visually) and HEADACHE (head starts pounding) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Fatigue, lower abdominal pain, nausea, vomiting, urinary frequency/urgency and weakness.
arm hurts/ legs hurt a little bit; light chills; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (arm hurts/ legs hurt a little bit) and CHILLS (light chills) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (arm hurts/ legs hurt a little bit) and CHILLS (light chills). At the time of the report, PAIN IN EXTREMITY (arm hurts/ legs hurt a little bit) and CHILLS (light chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication use was unknown Treatment information was unknown
some 11 weeks from 2nd injection, painful, half dozen canker sores broke out inside lips, lips purple and swollen, sensitive tongue. swished with warm salt water, took4K mg Lysine for four days to
This is a 51-year-old female with a past medical history of anxiety, PE, seizure disorder, orthostatic hypotension, chronic pain, opiate dependency who presents to the emergency room for 3 days of intractable nausea and vomiting.  Patient is asympomatic for COVID.Patient initially tested negative on 1/25/22 then turned positive 1/26/22.  Previously received Moderna 3/31/21, 4/28/21 & 1/16/22.  Discharged 1/28/22.
Administer Expired vaccine; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Administer Expired vaccine) in a 57-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Administer Expired vaccine). On 05-Nov-2021, EXPIRED PRODUCT ADMINISTERED (Administer Expired vaccine) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications was reported. Rx number: private. Patient name Private. Patient phone number private. Reporter given batch/lot number and date 026B21A(09-19-2021). No treatment medications was reported.
Spontaneous manifestation of symptoms similar to dermatographia 12 days after receiving the Moderna COVID-19 booster vaccine. When scratching or otherwise irritating skin, itchy welts form where the irritation occurred and persist for about 30 minutes. OTC hydrocortisone and antihistamines help with the symptoms but do not cure them. Symptoms have been lasting  for the past 2 days with no change.
Site: Pain at Injection Site-Mild, Systemic: Dizziness / Lightheadness-Medium, Additional Details: pt had near syniscope per emt.  pt did not sit and wait the 15 minute waiting period was walking around after 2 minutes of recieving the vacinne pt almost fainted called emt and was taken to er and released with diagnois of near syniscope no pain at the injection site just dizzy
Pt had blurry vision on the second day after immunization was given. It was blurry enough that she cannot read.
stroke; Information has been received from a lawyer regarding a case in litigation concerning a female patient (pt) of unknown age. No information was provided regarding the pt's past medical history, concurrent conditions, or concomitant medication use. On or about 05-JUN-2015, the pt was inoculated with zoster vaccine live (ZOSTAVAX) (dose, route of administration, vaccination site, lot # and expiry date were not specified) for routine health maintenance and for its intended purpose: the prevention of shingles (herpes zoster). Shortly receiving zoster vaccine live (ZOSTAVAX), (onset date not further specified), the pt suffered a stroke. As a direct and proximate result of the Company's defective zoster vaccine live (ZOSTAVAX) vaccine, the pt's symptoms have resulted in physical limitations not present prior to using the product. The pt also experienced mental and emotional distress due to resulting physical limitations and seriousness of the pt's condition. As a result of the manufacture, marketing, advertising, promotion, distribution and/or sale of zoster vaccine live (ZOSTAVAX), the pt sustained severe and permanent personal injuries. Further, as a tragic consequence of the Company's wrongful conduct, the pt suffered serious, progressive, permanent, and incurable injuries, as well as significant conscious pain and suffering, mental anguish, emotional distress, loss of enjoyment of life, physical impairment and injury. As a direct and proximate result of the Company's conduct, the pt has suffered and incurred damages, including medical expenses; the loss of accumulations; and other economic and non-economic damages. The outcome of the event was not resolved. The event of stroke was considered to be related to zoster vaccine live (ZOSTAVAX).  Upon internal review, the event of stroke was determined to be medically significant.  The event of stroke was considered to be disabling.  Additional information has been requested.
88 yr/o female with pmh for stroke (no residual) hld, htn, ckd, chf, atrial fib on Eliquis and osteoporosis who presented to the ed with left leg weakness and diarrhea.  Over the last few days she reports lle weakness/numbness her symptoms were reported to be intermittent until this am and says they were worse/constant. She was unable to bear weight on the leg d/t the weakness. There has been no known trauma or injuries. No arm weakness, visual disturbances, dizziness or difficulty with speech. Additionally she reports several episodes of black watery stools and intermittent non-productive cough for the last 4 days. No recent abx, no fevers/chills or abd pain. She is on Eliquis.-denies any bright red blood, or urinary complications. She has been vaccinated for COVID.  No other complaints at this time
stored in the freezer by mistake, No patients received; This case was reported by a pharmacist via call center representative and described the occurrence of intercepted product storage error in a patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced intercepted product storage error. On an unknown date, the outcome of the intercepted product storage error was unknown.  Additional details were provided as follows: The age at vaccination was not applicable for this report. The pharmacist stored the Shingrix in the freezer by mistake however the patients did not receive a dose of the frozen vaccines which led to intercepted product storage error. The pharmacist cut off the communication after receiving the information about Shingrix stability information. So, consent to follow up was not asked and callback to ask was not successful.
Excruciating side effects. It started with a headache, and now the intense pain has progressed behind my ear, neck and I am unable to swallow, open my mouth etc. I went to my general doctor on 04/15/21 where he thought I might have blood clot, which was ruled out negative by performing CT Scan. I was given pain killer medicine last Thursday. On Friday the 16th  the pain got even worse with medicine, my Doctor told me to go to Emergency Department. I was given a stronger cocktail for drugs and a second CT scan of my throat was done. ED physician Dr. Winter verified that it was reaction to COVID vaccine as your body is trying to reject/cope with this  substance (?Your nerves are angry with you?)
After dose 2 I got swollen lymph node in armpit on the side of the injection as well as slight fever, chills,painful arm neck and back, and ears hurt 24hrs after injection.; After dose 2 I got swollen lymph node in armpit on the side of the injection as well as slight fever, chills,painful arm neck and back, and ears hurt 24hrs after injection.; After dose 2 I got swollen lymph node in armpit on the side of the injection as well as slight fever, chills,painful arm neck and back, and ears hurt 24hrs after injection.; After dose 2 I got swollen lymph node in armpit on the side of the injection as well as slight fever, chills,painful arm neck and back, and ears hurt 24hrs after injection.; After dose 2 I got swollen lymph node in armpit on the side of the injection as well as slight fever, chills,painful arm neck and back, and ears hurt 24hrs after injection.; After dose 2 I got swollen lymph node in armpit on the side of the injection as well as slight fever, chills,painful arm neck and back, and ears hurt 24hrs after injection.; After dose 2 I got swollen lymph node in armpit on the side of the injection as well as slight fever, chills,painful arm neck and back, and ears hurt 24hrs after injection.; This is a spontaneous report from a non-contactable consumer (patient herself). A 39-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number: EW0187, Expiration date: not reported), via an unspecified route of administration in left arm on 06Jun2021 at 10:45 AM (at the age of 39-years-old) as dose 2, single for COVID-19 immunization. The patient was not diagnosed with COVID-19 prior vaccination. The patient was not tested for COVID-19 post vaccination. The patient did not receive any other vaccine in four weeks of vaccination. The patient's medical history was none. The patient's concomitant medication included carbofix received in two weeks of vaccination. The patient historical vaccine included bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number: EW0185, Expiration date: not reported), via an unspecified route of administration in right arm on 16May2021 at 01:00 PM (at the age of 39-years-old) as dose 1, single for COVID-19 immunization and experienced Injection site redness. On 07Jun2021 at 12:00 AM, the patient reported after dose 2 that she got swollen lymph node in armpit on the side of the injection as well as slight fever, chills, painful arm neck and back, and ears hurted 24hrs after injection. The adverse events resulted in doctor or other healthcare professional office or clinic visit. The patient did not receive any treatment in response to the events. The outcome of the event was resolving.   No follow-up attempts are possible. No further information is expected.
10x7 warm, red, swollen left deltoid localized reaction to DTAP.  Tylenol, warm compress.
died of SIDS; pt was suffering from viral influenza sx; mom described as vomiting the previous day; flu-like sx;
First Booster dose: Arm hurt/Second Booster Dose: Arm hurting; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP), Program ID. The reporter is the patient.  A 45-year-old female patient received BNT162b2 (BNT162B2), on 18Nov2021 as dose 3 (booster), single (Lot number: FD0809) at the age of 45 years, in right arm for covid-19 immunization. The patient's relevant medical history was not reported. There were no concomitant medications. Vaccination history included: BNT162b2 (First dose: 20Mar2021, lot: ER2613, NDC: Unknown , expiration: unknown, route of administration: upper right arm), administration date: 20Mar2021, when the patient was 44-year-old, for COVID-19 Immunization; BNT162b2 (second dose: 10Apr2021 , lot: ER8731, NDC: unknown, expiration: unknown , route of administration: upper right arm), administration date: 10Apr2021, when the patient was 44-year-old, for COVID-19 Immunization. The following information was reported: PAIN IN EXTREMITY (non-serious), outcome "recovering", described as "First Booster dose: Arm hurt/Second Booster Dose: Arm hurting".  Additional information: it was noted that after the second booster dose, the arm hurt; it barely hurt as of the reporting, however  if  the shoulder is raised up, the arm pain would be felt. Otherwise, it was not bothersome. If moves arm really high would only be doing it to find out if arm hurts or not. Arm hurting was improving.
Dark urine; Arm pain; A spontaneous report was received from a consumer (caregiver) concerning her mother, a 78-year-old, female patient, who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced dark urine/chromaturia and arm pain/pain in extremity.  The patient's medical history, as provided by the reporter, included allergy to sulfurs and lung cancer. Concomitant medications reported included bp medication, cholesterol medication and cancer pill.   On 13 Jan 2021, prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 (Lot number: unknown) through unknown route of administration in the upper left arm for prophylaxis of COVID-19 infection.   On 13 Jan 2021, the patient experienced dark urine and arm pain.  Lab details were not provided by the reporter.  Treatment for the events were unknown.  Action taken with mRNA-1273 in response to the events were not reported.   The outcome of the events dark urine and arm pain were unknown.
Pt Pt had already received the first 3 shots. Asked pt if he was ok and he stated yes. Pt was nervous. After the hepatitis shot pt's face was pale, he lowered his head and passed out. Ammonia inhalant started and pt's body started to seizure X 30 seconds. Care given and pt come out of it without any problem. Went home without any problem.
Severe joint pain in ankles, knees, neck, shoulders, and elbows. Headache with low grade fever. Doesn't respond well to Tylenol. Symptoms lessening as of 04/06/2021.
Pt was seen for a well visit on 6/23/23. 2 weeks prior he had a horsefly sting and had to go to the ED for epi due to facial swelling and hives. Was given a course of steroids, famotidine, benadryl and symptoms eventually resolved. Was well at WCC 6/23.  Received menquadfi vaccine.  Later that night had redness around the injection site, minor swelling but no other rash. The next day it was swollen/hot/itchy.  Thought to be a local reaction.  However 2 nights later he began having hives:  initially on  his back, groin, and chest.  They continued to spread but would fade a bit with benadryl and then come back full force.  Went to the ED 6/26 where he was given prednisone. Currently taking prednisone 60mg q d, benadryl or hydroxyzine.  Uritcaria continue to come and go. Concern for reaction to Menquadfi vaccine since had local reaction and then systemic hives. No angioedema, wheeze, vomiting.  Would not repeat this vaccine w/o allergy evaluation.
Patient is a 81 y.o. female patient of MD with history of recent diagnosis respiratory failure (requiring supplemental oxygen), recent C. difficile infection, COPD, PAF, hypertension presented to hospital with fevers, myalgias. Recent admission to hospital 8/8/23 - 8/11/23 for acute resp failure due to pneumonia COPD and pulmonary HTN. Was discharged home on doxycycline. Hospital course was complicated by acute diverticulitis and C diff colitis(found on day of discharge)   Covid-19 Virus Infection Date of onset of symptoms: Unsure since patient has had 3 prior hospitalizations in the last month for respiratory issues and pneumonia (approximately beginning of July 2023). Symptoms  Symptoms present on admission: Fevers, malaise, cough Date of covid positive test: 08/14/23 (COVID tests on 07/28/23 and 08/08/23 negative) Vaccination status: vaccinated Imaging: CXR: possible airspace disease in left lung base. CT chest 08/08/23 showed small left-sided pleural effusion/infiltrate.  Oxygen requirements on admission: 2 L nasal cannula, which patient has been using intermittently for the last month. Current oxygen requirements: requiring 1 L n/c, especially with ambulation  Consultants following: Infectious disease  Medical therapy: completed doxycycline(from previous admission), was given 1 dose of IV steroids in ED. Paxlovid contraindicated with Xarelto. Per ID given remdesivir x 3 days(completed 8/17) Anticipated special isolation end date: 08/19/23   Chronic respiratory failure Has been requiring supplemental oxygen (2 L nasal cannula) intermittently with exertion for the last couple of weeks. In setting of recent hospitalizations for COPD exacerbations and pneumonia as well as history of pulmonary hypertension and untreated OSA. Requiring 2 L nasal cannula on admission. Evaluated by pulmonology team during last hospitalization.  Breathing treatments as needed. Home oxygen evaluation completed- 1 L with rest and 2 L with ambulation   C. difficile infection Watery stool for the last 4 days. Diagnosed with C. difficile infection on 08/11/23. Continue oral vancomycin, complete 7 more days on discharge, pt has medication at home from prior hospitalization Diarrhea slowly improving    PAF Rate controlled. Resume xarelto. Not on rate controller medications.  Allergies noted to metoprolol and diltiazem   COPD No gross signs of acute exacerbation. On Trelegy at home, transitioned to Spiriva and Dulera here  Breathing treatments as needed.CKD Creatinine is 0.98; GFR 60 (baseline GFR in the 50s). Monitor renal function closely.   Hypertension Normotensive on admission. Now SBP running 140-160s Restarted home Losartan. Added Hydralazine 25 mg TID, however HRs in 100s, will discontinue Allergies noted to metoprolol and diltiazem Started norvasc 5 mg daily, resume on discharge    Hyponatremia Sodium 130(8/16), likely due to decreased appetite and diarrhoea  Trending down, 128(8/18) LR 500 cc bolus ordered, encouraged oral salt intake Started LR 75 cc/hr x 10 hours  Na improved to 131 today   Generalized weakness Poor appetite Started 8/14. Feels weak PT/OT- no therapy needs
Information has been received from a physician concerning a 15 month old patient who on an unspecified date was vaccinated with a dose of ROTATEQ (lot # not reported). On an unspecified date the "patient developed rotavirus after getting ROTATEQ" and was hospitalized. Unspecified laboratory test was performed (result not provided). The patient sought unspecified medical attention. The outcome of developed rotavirus was unknown. Additional information has been requested.
Narrative:  Patient with historical report of nausea and vomiting from flu vaccine. No other information reported. Unknown time, date, vaccine, or locations of vaccination
Presented to hospital on Nov 10 2021. This is a 63-year-old female with past medical history of thyroid dysfunction who comes for evaluation after being found on the ground, covered in stool and vomit.  Fall  with Rt hip pain.
An expired Covid-19 pfizer vaccine was administered to the patient on 4/18/22.  The vaccine expired on 4/18/22 at 10am.  The error was discovered on 4/29/22. On 5/3, a COVID-19 Vaccine temperature related enquiry form was filled out and emailed to Pfizer.  On 5-9-22 at 7:51am, we received an email from Pfizer's quality team stating they do not have stability data to support our excursion from prescribed storage conditions. We have reached out to our affected patients informing them of the situation and offered to revaccinate them if they choose to. Spoke with patient on 5-9 and he will get revaccinated.
45-60 minutes after receiving the vaccine she had numbness on the left side of her face/cheek associated with some mild swelling to the area. Maybe some mild left tongue swelling. Normal swallowing, normal breathing. No cough. No vomiting or diarrhea. No rash. She called an urgent care who recommended Benadryl, which helped minimize the tingling sensation and swelling over the next 2 days. Over the following week she had soreness at her left jaw joint near her ear and some left eye dryness. No facial droop. Normal blinking and smiling. No facial muscle weakness noticed. She was not sick when she received the vaccine. No new medications. Tolerates NSAIDs normally without reaction. No facial fillers. Never had anaphylaxis before to anything -- foods, medications, injectables, other vaccines. No known PEG allergy. Has not used Miralax before.
High fever up to 101 (my normal temp is around 96.5), the highest temp I got with influenza was 99.0 so this was very high for me.  Chills, shaking, dizziness, nausea, and vomiting.  At about 24 hours I developed a terrible migraine.  My fevers persisted despite taking ibuprofen.  At about 48 hours I was finally able to keep fevers down and am now feeling better.  The dizziness was so bad my husband had to walk me to the bathroom to throw up.  The fever and chills were so bad I couldn't rest for longer than 5-15 minute increments.
Information has been received from a registered nurse concerning a 65 year old female patient with hypertension, gastrooesophageal reflux disease, hyperlipidaemia, depression and opioid analgesic allergy, who on 14-SEP-2010 was vaccinated with PNEUMOVAX 23 (Lot # 666639/0564Z, Exp 09-OCT-2010) (route no reported). Concomitant therapy included citalopram, ZIAC, NEXIUM and LIPITOR. On 15-SEP-2010 the patient experienced redness, swelling and heat at injection site. Patient was given DEPO-MEDROL. At the time of the report, the patient was recovering. There were no laboratory tests performed. The patient sought unspecified medical attention. Follow up information has been received from the registered nurse concerning the 65 year old female patient who on 14-SEP-2010 was vaccinated with PNEUMOVAX 23 (Lot # 666639/0564Z, Exp 09-OCT-2010) (route no reported) into her left arm. It was reported that there were no illness at time of vaccination. On 14-SEP-2010 the patient developed left upper extremity pain, warmth and malaise. The patient's final outcome was not reported. Follow-up information has been received from the registered nurse who reported that no further appointments or follow-up were made for the patient. The outcome of events was unknown. Additional information is not expected.
Pt. was administered the flu- shot with a 5/8 inch needle instead of 1 inch. No adverse effect